Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
asymptomatic
axonal degeneration
Barkhof MR criteria for MS
BENEFIT study
brain atrophy
brain volume
brainstem, lesion of
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, oligoclonal IgG in
cervical spine
children
controversies in neurology
cop 1
corpus callosum, lesion of
diagnostic criteria
differential diagnosis
disability, neurological
efficacy
gadolinium
hydrocephalus, exvacuo
interferon
interferon beta 1-a
interferon beta 1-b
McDonald criteria for MS
misdiagnosis
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, demyelinating disease
MRI, serial
MRI, spinal cord
MRI, volumetry
multiple sclerosis
multiple sclerosis, asymptomatic
multiple sclerosis, conversion to clinically definite
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, disability status scale
multiple sclerosis, monosymptomatic
multiple sclerosis, MRI conversion
multiple sclerosis, MRI criteria
multiple sclerosis, preclinical
multiple sclerosis, prognosis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
neurologic disease, diagnoses of
posterior fossa
posterior fossa, lesion of
prognosis
review article
risk factors
safety
spinal cord
spinal cord, cervical
spinal cord, lesion of
treatment of neurologic disorder
ventricular enlargement
visual evoked response
white matter disease
workup
Showing articles 950 to 1000 of 4180 << Previous Next >>

Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997

Doctors & Pts Don't Agree:Cross Sectional Study of Pts' & Doctors'Perceptions & Assessments of Disability in MS
BMJ 314:1580-1583, Rothwell,P.M.,et al, 1997

The Impact of Inpatient Rehabilitation on Progressive Multiple Sclerosis
Ann Neurol 42:236-244, Freeman,J.A.,et al, 1997

Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997

Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997

Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997

Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997

Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997

Serum Angiotensin-Converting Enzyme in Multiple Sclerosis
Arch Neurol 54:1012-1015, Constantinescu,C.S.,et al, 1997

Hemiageusia:An Unusual Presentation of Multiple Sclerosis
JNNP 54:657, Pascual-Leone,A.,et al, 1997

Serial Neuropsychological Assess & Magnetic Resonance Imagingf Analysis in Multiple Sclerosis
Arch Neurol 54:1018-1025, Hohol,M.J.,et al, 1997

Randomised Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
Lancet 349:902-906, 8931997., Barnes,D.,et al, 1997

Frequency and Significance of Antinuclear Antibodies in Multiple Sclerosis
Neurol 49:857-861, Collard,R.C.,et al, 1997

Olfactory Dysfunction in Multiple Sclerosis
(Letter) NEJM 336:1918-1919997., Doty,R.L.,et al, 1997

Assessment of Olfaction in Multiple Sclerosis:Evidence of Dysfunction by Olfactory Evoked Response and Identification Tests
JNNP 63:145-151, Hawkes,C.H.,et al, 1997

Epstein-Barr Virus Encephalomyelitis Diagnosed by Polymerase Chain Reaction:Detection of the Genome in the CSF
Neurol 48:1351-1355, Tselis,A.,et al, 1997

Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997

Unusual Causes of Headache
Neurol 48:1494-1499, Ramadan,N.M., 1997

Lymphoproliferative Disorders and Motor Neuron Disease:An Update
Neurol 48:1671-1678, Gordon,P.H.,et al, 1997

Quality of Life Among Persons with Multiple Sclerosis and Their Caregivers
Neurol 48:74-80, Aronson,K.J., 1997

Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997

A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of Influenza Immunizaation in MS
Neurol 48:312-314, Miller,A.E.,et al, 1997

HLA Typing in Acute Optic Neuritis, Relation to MS & Magnetic Resonance Imaging Findings
Arch Neurol 54:76-80, Frederiksen,J.L.,et al, 1997

Correlation of Clinical, Magnetic Resonance Imaging, and Cerebrospinal Fluid Findings in Optic Neuritis
Ann Neurol 41:392-398, Jacobs,L.D.,et al, 1997

Volumetric MRI Analysis Comparing Subjects Having Attention-Deficit Hyperactivity Disorder with Normal Controls
Neurol 48:589-601, Filipek,P.A.,et al, 1997

Neuroanatomy in Rett Syndrome:Cerebral Cortex and Posterior Fossa
Neurol 48:399-407, Subramaniam,B.,et al, 1997

Longitudinal Change in Basal Ganglia Volume in Patients with Huntington's Disease
Neurol 48:394-399, Aylward,E.H.,et al, 1997

Medial Temporal Lobe Volumetrics in Traumatic Brain Injury
AJNR 18:25-28, Jack,C.R.,et al, 1997

Multiple Sclerosis Presenting as Transverse Myelopathy:Clinical and MRI Features
Neurol 48:65-73, Simnad,V.I.,et al, 1997

Cavernous Angioma of the Brain Stem Mimicking Multiple Sclerosis
NEJM 336:875-876, Vrethem,M.,et al, 1997

Clinicopath Conf
Oligodendroglioma, Mixed with Low-Grade Astrocytoma, Multiple Sclerosis, Case 12-1997, NEJM 336:1163, 11717., 1997

Concurrence of Multiple Sclerosis and Brain Tumor:Clinical Considerations
Neurol 48:1330-1333, Khan,O.A.,et al, 1997

A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997

Adult-Onset Subacute Sclerosing Panecephalitis:Case Reports and Review of the Literature
Mov Dis 12:342-353, Singer,C.,et al, 1997

Refractory Epilepsy:Comparison of MR Imaging, CT, and Histopathologic Findings in 117 Patients
Radiology 201:97-105, Bronen,R.A.,et al, 1996

Bilateral Ptosis Due to Mesencephalic Lesions with Relative Preservation of Ocular Motility
J Neuro-Ophthalmol 16:258-263, Martin,T.J.,et al, 1996

Motor Neuron Disease, Lymphoproliferative Disease, and Bone Marrow Biopsy
Muscle & Nerve 19:1334-1337996., Louis,E.D.,et al, 1996

Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996

Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996

Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996

Increased Writing Activity in Neurological Conditions:A Review and Clinical Study
JNNP 61:510-514, vanVugt,P.,et al, 1996

Hypothermia in Multiple Sclerosis
JNNP 61:369-375, White,K.D.,et al, 1996

Treatment with Oral 3, 4 Diaminopyridine Improves Leg Strength in Multiple Sclerosis Patients
Neurol 47:1457-1462, Bever,C.T.,et al, 1996

Age on Onset, Sex, & Cardiomyopathy as Predictors of Disability and Survival in Friedreich's Disease
Neurol 47:1260-1264, DeMichele,G.,et al, 1996

Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996

Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996

Triple Dose of Gadolinium-DPTA and Delayed MRI in Patients with Benign Multiple Sclerosis
JNNP 60:526-530, Filippi,M.,et al, 1996

Idiopathic Transverse Myelitis:MR Characteristics
AJNR 17:1151-1160, Choi,K.H.,et al, 1996

Serial MRI Studies in Pathologically Verified Balo's Concentric Sclerosis
J Comput Assist Tomogr 20:732-735, Chen,C-J.,et al, 1996

Acute Stroke with Atrial Fibrillation:The Copenhagen Stroke Study
Stroke 27:1765-1769, Jorgensen,H.S.,et al, 1996



Showing articles 950 to 1000 of 4180 << Previous Next >>